Healthcare and Medical
Healthcare and Medical
home | healthcare and medical | company profile
QLT Inc - Premium Company Profile (Datamonitor)
- Market: Healthcare and Medical
- Published Date: 14/01/2008
- Report Title: QLT Inc - Premium Company Profile
- Table of Contents: View Table of Contents
- Report Type: Company Profile
- Country: Global
- Number of Pages: 55
Introduction
QLT was originally focused on discovering, developing and commercializing innovative therapies in the fields of ophthalmology and dermatology. In 2006, the company changed its focus to purely research and development by selling its manufacturing facility to Tolmar Pharmaceuticals.
Scope
Contains corporate strategy, value chain presence and SWOT Analysis Provides detailed business description, segment analysis, 5-year financial trends, key products and key competitors Includes information on suppliers/ partners, shareholding structure and key employees with biographies
Highlights
QLT has two marketed products: Visudyne for the treatment of wet age-related macular degeneration (AMD), pathologic myopia and presumed ocular histoplasmosis and Eligard for the palliative treatment of advanced prostate cancer.
QLT derives its revenues form of product sales (net product revenue and royalties), contract research and development, and licensing and milestones. The company enters into commercial license agreements with pharmaceutical and biotechnology companies to market its products.
The company's total revenues increased at a CAGR of 11.9% during 2002-2006, from $110.5 million to $175.1 million. This represents an absolute total growth of +$64.6 million for total revenues. The company's biggest contributor to revenue growth during 2002-2006 was product sales of Visudyne and Eligard.
Reasons to Purchase
Access all the important information and analysis on the company in a single report Understand company's strengths, weaknesses, opportunities and threats along with business strategy and value chain Gain access to company's adjusted five year financial data along with key ratios and market capitalization
Scope
Highlights
Reasons to Purchase
Purchase Information
There are various ways to purchase products from our site. Select the report title(s) you are interested in, and add it to your basket. At the Checkout page, you will be requested to submit your details. You will then have the option to pay via various methods: Debit Card ; Credit Card ; Purchase via Invoice (inc. Purchase Order no. if required) and Paypal. Companiesandmarkets.com accepts Visa, MasterCard, Diners, American Express, JCB and all the major credit cards. Companiesandmarkets.com uses RBSWorldpay.
Once you have purchased your report(s), you will receive a confirmation email. You will then either be able to download your report(s) immediately from your Customer Area in PDF format, or the report(s) will be emailed to you directly, depending on the agreement we have with the publisher. Orders that are deliverable via email which are taken outside of working hours will be delivered next business day.
Please note, if you purchase by invoice, you will receive your report(s) once payment has been received. If you have any questions about how to order, please Contact Us.
